Qube Research & Technologies (QRT)
BIIB icon

Qube Research & Technologies (QRT)’s Biogen BIIB Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$39M Buy
+212,921
New +$39.2M 0.04% 532
2025
Q4 		– Sell
-121,607
Closed -$19.9M – 3683
2025
Q3 		$17M Sell
121,607
-621,702
-84% -$84M 0.02% 986
2025
Q2 		$93.4M Sell
743,309
-483,400
-39% -$60.2M 0.09% 269
2025
Q1 		$168M Buy
1,226,709
+135,867
+12% +$19.4M 0.19% 120
2024
Q4 		$167M Buy
1,090,842
+741,497
+212% +$125M 0.22% 96
2024
Q3 		$67.7M Buy
349,345
+335,113
+2,355% +$70.1M 0.1% 255
2024
Q2 		$3.3M Sell
14,232
-86,613
-86% -$18.8M 0.01% 1445
2024
Q1 		$21.7M Buy
+100,845
New +$23.6M 0.03% 544
2023
Q4 		– Sell
-6,328
Closed -$1.63M – 4343
2023
Q3 		$1.63M Sell
6,328
-42,041
-87% -$11.2M ﹤0.01% 1487
2023
Q2 		$13.8M Buy
+48,369
New +$14.4M 0.05% 445
2023
Q1 		– Sell
-228,626
Closed -$63.3M – 2550
2022
Q4 		$63.3M Buy
+228,626
New +$64.6M 0.34% 48
2022
Q3 		– Sell
-18,881
Closed -$3.85M – 2517
2022
Q2 		$3.85M Sell
18,881
-143,066
-88% -$29.2M 0.03% 578
2022
Q1 		$34.1M Buy
161,947
+146,864
+974% +$31.9M 0.29% 67
2021
Q4 		$3.62M Sell
15,083
-44,123
-75% -$11.3M 0.03% 647
2021
Q3 		$16.8M Sell
59,206
-17,445
-23% -$5.72M 0.21% 109
2021
Q2 		$26.5M Buy
+76,651
New +$23.2M 0.3% 53
2021
Q1 		– Sell
-28,151
Closed -$6.89M – 1918
2020
Q4 		$6.89M Buy
28,151
+8,045
+40% +$2.08M 0.1% 235
2020
Q3 		$5.7M Sell
20,106
-30,278
-60% -$8.44M 0.08% 318
2020
Q2 		$13.5M Buy
50,384
+47,076
+1,423% +$14.2M 0.2% 118
2020
Q1 		$1.05M Buy
+3,308
New +$1M 0.04% 376
2019
Q3 		– Sell
-10,176
Closed -$2.38M – 260
2019
Q2 		$2.38M Buy
+10,176
New +$2.35M 0.57% 36
2018
Q4 		– Sell
-10,440
Closed -$3.69M – 359
2018
Q3 		$3.69M Buy
10,440
+9,429
+933% +$3.25M 0.49% 45
2018
Q2 		$293K Sell
1,011
-237
-19% -$66.6K 0.18% 123
2018
Q1 		$341K Buy
+1,248
New +$387K 0.13% 96

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Qube Research & Technologies (QRT)'s BIIB Position: Q1 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Biogen (BIIB) in Q1 2026: 212,921 shares worth $39M. The stake represents 0.04% of the portfolio and ranks #532 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in BIIB as recently as Q3 2025.

Qube Research & Technologies (QRT) first reported a position in BIIB in Q1 2018 and has held it in 24 quarters since. The position peaked at $168M in Q1 2025. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Qube Research & Technologies (QRT) held 212,921 shares of Biogen worth $39M as of Q1 2026.
  • Biogen was a new Qube Research & Technologies (QRT) position in Q1 2026.
  • Biogen made up 0.04% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #532 holding.
  • Qube Research & Technologies (QRT) first reported a position in Biogen in Q1 2018 and has held it in 24 quarters since.
  • Qube Research & Technologies (QRT)'s Biogen position peaked at $168M in Q1 2025.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.